Apiam Animal Health Ltd

Consumer Cyclical AU AHX

0.875AUD
-(-%)

Last update at 2026-03-10T23:00:00Z

Day Range

0.880.88
LowHigh

52 Week Range

0.300.88
LowHigh

Fundamentals

  • Previous Close 0.88
  • Market Cap164.41M
  • Volume0
  • P/E Ratio-
  • Dividend Yield2.30%
  • EBITDA19.40M
  • Revenue TTM206.92M
  • Revenue Per Share TTM1.14
  • Gross Profit TTM 46.88M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax 2.86M 7.06M 3.17M 6.47M 7.04M
Minority interest -0.03200M 0.02M 0.11M 0.10M 1.00M
Net income 0.83M 4.93M 2.28M 4.64M 5.08M
Selling general administrative 90.15M 90.67M 82.84M 61.96M 43.26M
Selling and marketing expenses - 68.50M - - -
Gross profit 137.03M 137.16M 121.88M 96.30M 70.26M
Reconciled depreciation 12.76M 11.97M 10.23M 8.36M 6.34M
Ebit 7.16M 11.55M 6.35M 7.64M 7.85M
Ebitda 19.92M 23.52M 16.57M 16.00M 14.19M
Depreciation and amortization 12.76M 11.97M 10.23M 8.36M 6.34M
Non operating income net other - - - - -
Operating income 12.44M 12.36M 6.57M 7.78M 8.21M
Other operating expenses 194.49M 157.89M 184.82M 149.02M 118.03M
Interest expense 5.65M 5.52M 3.18M 1.17M 0.81M
Tax provision 2.00M 2.15M 0.99M 1.93M 2.04M
Interest income 5.66M 5.47M 3.72M 1.48M 1.10M
Net interest income -5.64700M -5.52300M -3.77400M -1.57000M -1.17600M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 2.00M 2.15M 0.99M 1.93M 2.04M
Total revenue 206.92M 204.66M 191.76M 157.06M 126.18M
Total operating expenses 124.59M 124.80M 115.31M 86.71M 61.98M
Cost of revenue 69.89M 67.49M 69.88M 60.76M 55.92M
Total other income expense net -9.57800M -5.29900M 0.37M -1.54400M -0.06500M
Discontinued operations - - - - -
Net income from continuing ops 0.86M 4.91M 2.17M 4.54M 5.00M
Net income applicable to common shares 0.83M 4.93M 2.28M 4.64M 5.08M
Preferred stock and other adjustments - - - - -
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 255.80M 255.78M 246.04M 199.04M 156.63M
Intangible assets 15.90M 17.48M 18.30M 13.25M 6.45M
Earning assets - - - - -
Other current assets 1.78M 2.24M -0.00100M 0.32M 0.17M
Total liab 134.72M 133.75M 128.14M 90.36M 75.77M
Total stockholder equity 121.03M 122.02M 117.87M 108.55M 79.86M
Deferred long term liab - - 3.31M 1.52M 1.98M
Other current liab 22.90M 19.98M 1.22M 0.50M 0.19M
Common stock 137.33M 135.77M 134.84M 127.25M 101.01M
Capital stock 137.33M 135.77M 134.84M 127.25M 101.01M
Retained earnings 15.66M 18.47M 15.34M 13.76M 11.64M
Other liab - - 4.77M 4.67M 2.08M
Good will 146.97M 150.12M 145.31M 113.58M 88.62M
Other assets - 0.00000M 3.60M 5.94M 5.47M
Cash 2.52M 1.76M 3.60M 2.85M 2.15M
Cash and equivalents - - - - -
Total current liabilities 34.24M 33.74M 33.27M 28.77M 24.37M
Current deferred revenue - 1.77M 17.81M 16.06M 12.21M
Net debt 100.02M 100.02M 94.42M 60.55M 52.89M
Short term debt 6.00M 5.91M 7.92M 6.47M 5.73M
Short long term debt - - 2.93M 2.91M 2.82M
Short long term debt total 102.54M 101.78M 98.03M 63.39M 55.04M
Other stockholder equity - -0.00000M -150.17600M -141.00500M -112.60600M
Property plant equipment - - 43.81M 31.64M 24.54M
Total current assets 32.63M 32.51M 34.73M 35.88M 33.31M
Long term investments 0.26M 0.27M 0.27M 0.27M 0.22M
Net tangible assets - - -42.43300M -16.76400M -13.23500M
Short term investments - - - - -
Net receivables 12.91M 13.37M 13.96M 13.62M 13.54M
Long term debt 61.47M 64.27M 66.07M 39.16M 34.89M
Inventory 15.42M 15.14M 15.47M 17.78M 16.04M
Accounts payable 5.34M 6.08M 6.32M 5.74M 6.25M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -31.95300M -32.21200M -32.30800M -32.45500M -32.79100M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.41M 17.48M - - -
Deferred long term asset charges - - - - -
Non current assets total 223.16M 223.27M 211.31M 163.17M 123.32M
Capital lease obligations 41.06M 37.51M 29.03M 21.31M 17.34M
Long term debt total - - 90.11M 56.92M 49.31M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -6.26000M -10.90700M -40.57000M -32.48300M -16.62100M
Change to liabilities - - -0.87100M -0.16900M 0.63M
Total cashflows from investing activities -6.26000M -10.90700M -40.57000M -32.48300M -16.62100M
Net borrowings -1.44200M -2.04000M 24.16M 1.29M -1.24800M
Total cash from financing activities -10.61600M -9.38600M 23.49M 18.14M 2.57M
Change to operating activities - - 1.19M 0.63M 0.36M
Net income 0.83M 4.93M 2.28M 4.64M 5.04M
Change in cash 0.76M -1.41500M 0.33M 0.69M -0.35900M
Begin period cash flow 1.76M 3.17M 2.85M 2.15M 2.51M
End period cash flow 2.52M 1.76M 3.17M 2.85M 2.15M
Total cash from operating activities 17.64M 18.88M 17.41M 15.04M 13.69M
Issuance of capital stock - - - 20.25M 6.00M
Depreciation - 11.97M 9.82M 8.36M 6.43M
Other cashflows from investing activities -0.56200M 0.13M -32.36500M 0.04M -11.64000M
Dividends paid -2.61100M -1.32200M 0.67M 2.36M 1.94M
Change to inventory 0.34M 1.55M 1.17M -0.66800M 1.89M
Change to account receivables 0.18M 0.44M 2.03M 1.35M -1.51900M
Sale purchase of stock - - 0.00000M -1.06900M -0.30000M
Other cashflows from financing activities -6.56300M -6.02400M 34.28M 28.01M 7.83M
Change to netincome - - 2.79M 0.60M 0.53M
Capital expenditures 6.81M 4.78M 8.21M 4.86M 4.98M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.15000M 2.45M 3.19M 0.68M 0.38M
Stock based compensation - 0.55M 0.57M 0.77M 0.34M
Other non cash items 17.79M -0.47800M 5.31M 2.04M 2.23M
Free cash flow 10.83M 14.01M 9.20M 10.17M 8.71M

Peer Comparison

Sector: Consumer Cyclical Industry: Personal Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AHX
Apiam Animal Health Ltd
- -% 0.88 - 18.90 0.79 1.36 1.28 13.28
PFP
Propel Funeral Partners Ltd
-0.08 1.79% 4.40 28.07 30.12 2.53 1.71 3.33 14.01
SHJ
Shine Justice Ltd
- -% 0.70 12.17 7.14 0.58 0.45 1.06 6.09
MFD
Mayfield Childcare Ltd
-0.065 15.85% 0.34 - 8.02 0.37 0.76 2.12 11.18
AFL
Af Legal Group Ltd
0.01 9.68% 0.17 - 0.04 0.57 1.64 0.68 5.14

Reports Covered

Stock Research & News

Profile

Apiam Animal Health Limited, a vertically integrated animal health company, provides veterinary products and services to production and companion, and equine animals in Australia. It operates through three segments: Clinical Vet Services, Feedlots, and Pigs. The company provides systems to assist in herd health programs; production advice; consulting services and products to assist in the prevention of animal diseases; technologies to manage compliance with legislative requirements on pharmaceutical use; advice and services in respect of animal welfare compliance; on-farm delivery of products via its own logistics capability; third party auditing services of industry quality assurance programs; technology development for animal health management; on-farm and on-line training; programs for clients; ancillary services, such as sales and/or delivery of genetics and associated products. The company engages in the provision of veterinary wholesale, laboratories, warehousing, and logistics services, as well as retail sale of animal health products. It also offers companion animal, dairy, swine and poultry, beef feedlot, equine, sheep, and genetic services, as well as diagnostics and custom vaccines. In addition, the company provides telemedicine, remote video, benchmarking, database analysis, and herd management software; and herd health management services through eCommerce. It provides its services through animal veterinary clinics. Apiam Animal Health Limited was founded in 1998 and is based in Bendigo, Australia. As of February 6, 2026, Apiam Animal Health Limited was taken private.

Apiam Animal Health Ltd

27-33 Piper Lane, Bendigo, VIC, Australia, 3550

Key Executives

Name Title Year Born
Dr. Christopher Irwin Richards B.Sc., BSc, BVSc, M.A.I.C.D. MD & Exec. Director NA
Mr. Matthew Brian White BAcc, CPA Chief Financial Officer NA
Mr. Brian Scutt M.B.A. Chief Operating Officer NA
Mr. Matt Gallagher FCIS, L.L.M. Gen. Counsel NA
Ms. Renee Waters B.Sc. Chief People Officer NA
Ms. Eryl Baron AGIA, B.A., C.A., CA Company Sec. NA
Dr. Christopher Irwin Richards B.Sc., BSc, BVSc, M.A.I.C.D. MD & Executive Director NA
Mr. Matt Gallagher FCIS, L.L.M. General Counsel NA
Ms. Eryl Baron AGIA, B.A., C.A. Company Secretary NA
Dr. Christopher Irwin Richards B.Sc., BSc, BVSc, M.A.I.C.D. MD & Executive Director NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.